ENDO: Disparities Seen in Access to Insulin Pumps for Youth With T1D
WEDNESDAY, June 15, 2022 (HealthDay News) — There are disparities in access to insulin pumps among youth with type 1 diabetes (T1D), according to a study presented at the annual meeting of the Endocrine Society, held from June 11 to 14 in Atlanta.Est…
Learn MoreStudy Compares DBT With Digital Mammography Screening
WEDNESDAY, June 15, 2022 (HealthDay News) — Compared with digital mammography, digital breast tomosynthesis (DBT) is not associated with a significant difference in the risk of interval invasive cancer or advanced cancer among women who are not at hi…
Learn MoreDisruption to Oncology Clinical Trials Seen Early in Pandemic
WEDNESDAY, June 15, 2022 (HealthDay News) — The COVID-19 pandemic resulted in significant disruption to oncology therapeutic clinical trials, with an initial decrease in new patient accruals and in newly activated trials, according to a study publish…
Learn MoreGenetic Variants in HMGCR Linked to Increased Cataract Risk
WEDNESDAY, June 15, 2022 (HealthDay News) — Genetically proxied inhibition of the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) gene, which mimics statin treatment, is associated with increased risk of cataract, according to a study publish…
Learn MoreOlder Adults With Type 1 Diabetes Have Lower Grip Strength
WEDNESDAY, June 15, 2022 (HealthDay News) — Diastolic blood pressure and grip strength appear to be consistently lower in aging individuals with type 1 diabetes (T1D), according to a study published online May 26 in the Canadian Journal of Diabetes.L…
Learn MoreRace-Free eGFR Equation IDs Kidney Failure, Mortality Risk
WEDNESDAY, June 15, 2022 (HealthDay News) — Using an estimated glomerular filtration rate (eGFR) equation with creatinine (cr) and cystatin C (cys) may be preferable for assessing racial differences in the risk of mortality and kidney failure with re…
Learn MoreAtogepant Prevents Migraine in Adults
WEDNESDAY, June 15, 2022 (HealthDay News) — Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 in JAMA Network Open.Richard B. Lipton, M.D., from Albert Einstein…
Learn MoreFDA Panel to Weigh Moderna Vaccine for Those Aged 6 to 17
TUESDAY, June 14, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s vaccine advisory panel will decide on Tuesday whether to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17.The panel…
Learn MoreOne Dead, 27 Hospitalized in U.S. Salmonella Outbreak Tied to Poultry
TUESDAY, June 14, 2022 (HealthDay News) — One person has died and 27 people have been hospitalized in a multistate Salmonella outbreak linked to backyard poultry, the U.S. Centers for Disease Control and Prevention says.Even if they appear healthy an…
Learn MoreEarly Identification Cuts Costs for Spinal Muscular Atrophy
TUESDAY, June 14, 2022 (HealthDay News) — Early identification and treatment of patients with spinal muscular atrophy can reduce the total associated financial costs, according to a study published online June 8 in Developmental Medicine & Child Neur…
Learn More